These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

393 related items for PubMed ID: 31114180

  • 1. Clinical burden of illness among patients with severe eosinophilic COPD.
    Müllerová H, Meeraus WH, Galkin DV, Albers FC, Landis SH.
    Int J Chron Obstruct Pulmon Dis; 2019; 14():741-755. PubMed ID: 31114180
    [Abstract] [Full Text] [Related]

  • 2. Exacerbation Frequency And Eosinophil Counts Among Patients With COPD Currently Prescribed Triple Therapy.
    Benson VS, Pascoe KC, Siddall J, Small M, Müllerová H.
    Int J Chron Obstruct Pulmon Dis; 2019; 14():2711-2723. PubMed ID: 31819403
    [Abstract] [Full Text] [Related]

  • 3. Comparative effectiveness of LABA-ICS versus LAMA as initial treatment in COPD targeted by blood eosinophils: a population-based cohort study.
    Suissa S, Dell'Aniello S, Ernst P.
    Lancet Respir Med; 2018 Nov; 6(11):855-862. PubMed ID: 30343028
    [Abstract] [Full Text] [Related]

  • 4. Exacerbations and health care resource use among patients with COPD in relation to blood eosinophil counts.
    Müllerová H, Hahn B, Simard EP, Mu G, Hatipoğlu U.
    Int J Chron Obstruct Pulmon Dis; 2019 Nov; 14():683-692. PubMed ID: 30962682
    [Abstract] [Full Text] [Related]

  • 5. Blood Eosinophil Counts, Withdrawal of Inhaled Corticosteroids and Risk of COPD Exacerbations and Mortality in the Clinical Practice Research Datalink (CPRD).
    Oshagbemi OA, Franssen FME, van Kraaij S, Braeken DCW, Wouters EFM, Maitland-van der Zee AH, Driessen JHM, de Vries F.
    COPD; 2019 Apr; 16(2):152-159. PubMed ID: 31117850
    [Abstract] [Full Text] [Related]

  • 6. The burden of chronic obstructive pulmonary disease associated with maintenance monotherapy in the UK.
    Edwards SC, Fairbrother SE, Scowcroft A, Chiu G, Ternouth A, Lipworth BJ.
    Int J Chron Obstruct Pulmon Dis; 2016 Apr; 11():2851-2858. PubMed ID: 27920512
    [Abstract] [Full Text] [Related]

  • 7. Single-inhaler triple therapy in patients with chronic obstructive pulmonary disease: a systematic review.
    Langham S, Lewis J, Pooley N, Embleton N, Langham J, Han MK, Chalmers JD.
    Respir Res; 2019 Nov 04; 20(1):242. PubMed ID: 31684965
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. When to use single-inhaler triple therapy in COPD: a practical approach for primary care health care professionals.
    Gaduzo S, McGovern V, Roberts J, Scullion JE, Singh D.
    Int J Chron Obstruct Pulmon Dis; 2019 Nov 04; 14():391-401. PubMed ID: 30863039
    [Abstract] [Full Text] [Related]

  • 10. Factors influencing treatment escalation from long-acting muscarinic antagonist monotherapy to triple therapy in patients with COPD: a retrospective THIN-database analysis.
    Hurst JR, Dilleen M, Morris K, Hills S, Emir B, Jones R.
    Int J Chron Obstruct Pulmon Dis; 2018 Nov 04; 13():781-792. PubMed ID: 29551894
    [Abstract] [Full Text] [Related]

  • 11. Current appraisal of single inhaler triple therapy in COPD.
    Lipworth B, Kuo CR, Jabbal S.
    Int J Chron Obstruct Pulmon Dis; 2018 Nov 04; 13():3003-3009. PubMed ID: 30319248
    [Abstract] [Full Text] [Related]

  • 12. Changes in COPD inhaler prescriptions in the United Kingdom, 2000 to 2016.
    Bloom CI, Elkin SL, Quint JK.
    Int J Chron Obstruct Pulmon Dis; 2019 Nov 04; 14():279-287. PubMed ID: 30774325
    [Abstract] [Full Text] [Related]

  • 13. Initiation of triple therapy maintenance treatment among patients with COPD in the US.
    Simeone JC, Luthra R, Kaila S, Pan X, Bhagnani TD, Liu J, Wilcox TK.
    Int J Chron Obstruct Pulmon Dis; 2017 Nov 04; 12():73-83. PubMed ID: 28053518
    [Abstract] [Full Text] [Related]

  • 14. Real-World Treatment Patterns of Multiple-Inhaler Triple Therapy Among Patients with Chronic Obstructive Pulmonary Disease in UK General Practice.
    Sansbury LB, Bains C, Lipson DA, Ismaila AS, Landis SH.
    Int J Chron Obstruct Pulmon Dis; 2021 Nov 04; 16():1255-1264. PubMed ID: 33986594
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Clinical characteristics and medication patterns in patients with COPD prior to initiation of triple therapy with ICS/LAMA/LABA: A retrospective study.
    Bogart M, Stanford RH, Reinsch T, Hull M, Buikema A, Hulbert E.
    Respir Med; 2018 Sep 04; 142():73-80. PubMed ID: 30170806
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Single inhaler triple therapy versus inhaled corticosteroid plus long-acting β2-agonist therapy for chronic obstructive pulmonary disease (TRILOGY): a double-blind, parallel group, randomised controlled trial.
    Singh D, Papi A, Corradi M, Pavlišová I, Montagna I, Francisco C, Cohuet G, Vezzoli S, Scuri M, Vestbo J.
    Lancet; 2016 Sep 03; 388(10048):963-73. PubMed ID: 27598678
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.